# Braskem lays bare creditor stalemate as Mexico unit’s finances unravel

*Filing details US$2.3bn debt, negative cash from 2026 and formal rejection of bondholders’ counterproposal.*

- Published: 2026-01-12
- Updated: 2026-01-13
- Section: Insights
- Tags: balance sheet stress, blue chip, bondholders, Braskem, Braskem Idesa, Capital Structure, corporate debt, emerging markets, Latin America, Mexico, Petrochemicals, Project Lavoisier, restructuring
- URL: https://brazilstockguide.com/insights/braskem-idesa-creditor-stalemate-restructuring/

![Braskem Idesa, Braskem, BAK, Mexico unit,](https://i0.wp.com/brazilstockguide.com/wp-content/uploads/2025/09/Braskem-Idesa-Mexico.jpg?fit=1024%2C426&ssl=1)

**By Brazil Stock Guide –** **Braskem** (**BRKM3, BRKM5, BRKM6; NYSE: BAK**) set out the breakdown in talks between its Mexican unit **Braskem Idesa** and bondholders after releasing the Project Lavoisier *Cleansing Materials* in a filing to Brazil’s securities regulator.

According to the material disclosure, the sides exchanged proposals and held in-person meetings but failed to reach agreement, with the company stating it did not accept the creditors’ terms. The documents expose a critical financial position at the Mexico subsidiary: roughly **US$2.3bn** in gross debt, accelerating cash burn and reliance on a deep restructuring to keep operations running.

**Structure under strain**
The papers describe a prolonged period of compressed margins across the petrochemicals cycle, structural constraints on ethane supply in Mexico and elevated logistics costs. Under a status-quo scenario, cash turns negative in **2026** and deepens to about **US$1.7bn** negative by **2029**, while debt remains largely unchanged at close to **US$2.3bn**.

**Numbers that don’t add up**
Projections point to **US$136m of EBITDA in 2026**, with net leverage above **44 times EBITDA**. Even by **2028**, after a gradual operational recovery, leverage still exceeds **21 times**, signalling that a cyclical rebound alone does not fix the balance sheet.

**What’s at stake**
Braskem Idesa’s proposal centres on a shareholder-backed, defensive solution. The package includes up to **US$300m** in a liquidity facility and **US$400m** of new equity to fund a tender offer. Bondholders would be offered two paths: an exchange at **par (100%)** into new notes due in **2033** with a **five-year interest holiday**, or a **55%** cash-out capped at **US$400m**. On a pro-forma basis, debt would fall to about **US$1.6bn**.

**Clash of proposals**
Creditors countered with a tougher plan, demanding **US$900m** of shareholder *new money*, including **first-lien debt at 11%**, additional equity injections and tighter control over collateral, covenants and capex. The divide reflects a core conflict: management seeks time and optionality until the cycle turns, while bondholders push for immediate value capture and greater operational control.

**Outlook**
With no agreement in place, Braskem Idesa’s restructuring is likely to drag on. As cash deteriorates ahead of the expected petrochemicals upturn, the risk of more coercive outcomes rises through **2026**, increasing pressure on shareholders and creditors to reach a swift resolution.

---

Source: Brazil Stock Guide, https://brazilstockguide.com/insights/braskem-idesa-creditor-stalemate-restructuring/